Pharmafile Logo

kelly smith

- PMLiVE

Virtual care – negotiating barriers to adoption offers glimpses of an exciting future

Digital tools and innovative healthcare promise to address pressing healthcare issues if they can satisfy concerns over access, security and affordability

- PMLiVE

HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics

EPG Health publishes new multi-stakeholder research report on The Future of HCP Engagement Impact

EPG Health

- PMLiVE

AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer

Approximately 7,400 new cases of the disease are diagnosed in the UK every year

- PMLiVE

BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer

More than 1.9 million cases of colorectal cancer were diagnosed globally in 2020

- PMLiVE

Stanford Medicine researchers find blood tests help predict organ failure

One in five adults aged 50 or older may have an organ ageing at an accelerated rate

- PMLiVE

GSK and GCOA report reveals global inequities in adult immunisation uptake

The report explored the social and structural factors of health in adult immunisation

- PMLiVE

A “Leaky Pipeline” and the Loss of Talented Female Physicians

A leaky pipeline that begins during medical school and extends throughout the training process means we lose many talented women, says Fatima Rodriguez, director of preventive cardiology and associate professor...

Medscape Education

- PMLiVE

Medscape Oncology’s Large Presence at ASH 2023

Medscape Education is returning to the annual ASH conference with eight symposia, two publications, and the opportunity for clinicians to challenge their knowledge with MedChallenge.The eight symposia will be held...

Medscape Education

Versatility! Top 10 benefits of virtual advisory boards

Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

Impetus Digital

- PMLiVE

Study identifies new amyloid-forming protein linked to early-onset dementia

The TAF15 protein is a new potential therapeutic for frontotemporal dementia

- PMLiVE

Roche shares positive late-stage results for inavolisib combination in advanced breast cancer

About 290,000 people in the US will be diagnosed with breast cancer in 2023

- PMLiVE

AbbVie to expand neuroscience pipeline with $8.7bn Cerevel Therapeutics acquisition

The deal includes a candidate currently in phase 3 testing as a treatment for Parkinson’s disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links